Sichuan University

This study tests whether adding low-dose radiation to standard chemotherapy and an immunotherapy drug can help people with extensive-stage small cell lung cancer live longer without their cancer growing. About 61 people who have not had prior treatment for this stage will receive…

This early-phase study tests whether adding low dose radiation and focused radiation (SBRT) to immunotherapy can be safe for people with advanced non-small cell lung cancer who have run out of standard options. Nine participants will receive the combination treatment at one hospi…

This study tests a new treatment for people with extensive stage small cell lung cancer who have not had prior therapy. It combines an experimental drug (AK104) with standard chemotherapy and low-dose radiation. The goal is to see if this combination is safe and helps control the…

This early-stage study aimed to test whether adding low-dose radiation to standard chemotherapy and two immunotherapy drugs (toripalimab and tifcemalimab) could be safe and tolerable for people with extensive-stage small cell lung cancer who had not been treated before. The study…